Reticulocyte parameters: Markers of early response to oral treatment in children with severe iron-deficiency anemia

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue 6, 2012, Pages

  Parodi, Emilia ^a,b   Giraudo, Maria Teresa ^b   Davitto, Mirella ^b   Ansaldi, Giulia ^b   Mondino, Anna ^b   Garbarini, Letizia ^b   Franzil, Annamartina ^b   Mazzone, Raffaela ^c   Russo, Giovanna ^d   Ramenghi, Ugo ^b  

^a MAURIZIANO HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c S ANNA HOSPITAL   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

children; iron deficiency anemia; reticulocyte hemoglobin content; reticulocytes

Indexed keywords

FERROUS SULFATE; HEMOGLOBIN;

ADOLESCENT; ARTICLE; ASYMPTOMATIC DISEASE; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFANT; IRON DEFICIENCY ANEMIA; IRON THERAPY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; RETICULOCYTE COUNT; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADOLESCENT; ANEMIA, IRON-DEFICIENCY; BIOLOGICAL MARKERS; CHILD, PRESCHOOL; FEMALE; HEMOGLOBINS; HUMANS; INFANT; INFANT, NEWBORN; IRON; MALE; PROGNOSIS; RETICULOCYTE COUNT; RETICULOCYTES; RETROSPECTIVE STUDIES;

EID: 84864377108     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182588996     Document Type: Article

References (14)

1. World Health Organization. Iron Deficiency Anemia:Assessment, Prevention, and Control-A Guide for Program Managers. Geneva, Switzerland: WORLD Health Organization WHO/ NHD/01.3; 2001.
2. Zeng X, Wu T. Iron Supplementation for Iron Deficiency Anemia in Children. Cochrane Database of Systematic Reviews. Chichester, UK: JOHN Wiley & Sons, Ltd; 2007.
3. Auerbach M. Should intravenous iron be upfront therapy for iron deficiency anemia? Pediatr Blood Cancer. 2011;56: 511-512.
4. Bansal G, Burton J, Win N, et al. Assessment of the efficacy of intravenous iron therapy (Venofers) in the treatment of iron deficiency anemia (IDA). ASH Annual Meeting Abstracts. 2010; 116: 4229.
5. Poma A, Diana K, McLaughlin J, et al. A head-to-head comparison of the safety and efficacy of ferumoxytol to iron sucrose for the treatment of iron deficiency anemia. ASH Annual Meeting Abstracts. 2010; 116: 5157.
6. Akarsu S, Taskin E, Yilmaz E, et al. Treatment of iron deficiency anemia with intravenous iron preprations. Acta Haematol. 2006;116:51-57.
7. Piva E, Brugnara C, Chiandetti L, et al. Automated reticulocyte counting: State of the art and clinical applications in the evaluation of erythropoiesis. Clin Chem Lab Med. 2010;48:1369-1380.
8. Sandoval C, Berger E, Ozkaynak MF, et al. Severe iron deficiency anemia in 42 pediatric patients. Pediatr Hematol Oncol. 2002;19:157-161.
9. Brugnara C. Use of reticulocyte cellular indicators in the diagnosis and treatment of haematological disorders. Int J Clin Lab Res. 1998;28:1-11.
10. Major A, Mathez-Loic F, Rohling R, et al. The effect of intravenous iron on the reticulocyte response to recombinant human erythropoietin. Br J Hematol. 1997;98:292-294.
11. Mittman N, Sreedhara R, Mushnick R, et al. Reticulocyte hemoglobin content predicts functional iron deficiency in haemodialysis patients receiving rHuEPO. Am J Kidney Dis. 1997;30:912-922.
12. Chuang CL, Liu RS, Wei YH, et al. Early prediction of response to intravenous iron supplementation by reticulocyte hemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. Nephrol Dial Transplant. 2003;18: 370-377.
13. Warady BA, Kausz A, Lerner G, et al. Iron therapy in the pediatric hemodialysis population. Pediatr Nephrol. 2004;19: 655-661.
14. Brugnara C, Lauter MR, Friedman AJ, et al. Reticulocyte haemoglobin content (CHr): Early indicator of iron deficiency and response to therapy. Blood. 1994;83:3100-3101.